Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Appyea Inc (QB) APYP

AppYea, Inc., a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring. The company developed the AppySleep app, an application with sensors that monitors physiological parameters during sleep; AppySleep, a biofeedback snoring treatment wristband; AppySleep LAB, a smartphone medical application that monitors breathing patterns during sleep and identifies sleep apnea episodes without direct contact with the user; and AppySleep PRO, a wristband for the treatment of sleep apnea using biofeedback in combination with the AppySleep LAB app. AppYea, Inc. was founded in 2012 and is headquartered in Gan Yavne, Israel.


OTCQB:APYP - Post by User

User Avatar Image
(6)
•••
  • ElliotGHX
Post by ElliotGHon Sep 08, 2022 9:46am
162 Views
Post# 34949074

AppYea received extension confirmation for strategic patent

AppYea received extension confirmation for strategic patent
AppYea Inc (OTC: APYP) received extension confirmation for strategic patent in UK, Germany and France $APYP
 
https://www.otcmarkets.com/stock/APYP/news/AppYea-Inc-OTC-APYP-received-extention-confirmation-for-strategic-patent-in-UK-Germany-and-France?id=371680
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities